Search results
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 11 hours agoWhether she was joking or not, she viewed the job as temporary—a way to get by before she resumed...
U.S. FDA set to reorganize its food division starting October
Reuters· 5 days agoThe U.S. Food and Drug Administration(FDA) said on Thursday it plans to restructure its food...
Outbreak: Tainted food sickens millions each year
KCTV 5 Kansas City· 1 day agoFor nearly two decades, the Government Accountability Office, the government’s watchdog, has implored four presidents and Congress to make improvements...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 3 days agoThe approach isn’t entirely new: The first antibody drug conjugate was approved by the Food and Drug...
U.S. FDA Set to Reorganize Its Food Division Starting October
US News & World Report· 5 days agoThe regulatory body had come under fire over its slow response to the infant formula shortage in 2022. The FDA said the reorganization will enable it to be more efficient and
Canadian Drug Importation May Undermine Intellectual Property Protection | JD Supra
JD Supra· 7 days agoThe Situation: Earlier this year, Florida became the first state to receive authorization for its Section 804 Importation Program ("SIP") from the U.S. Food and< ...
Doctors' Tips for Accessing Costly GLP-1 Therapies
Medscape· 2 days ago"Does your insurance cover anti-obesity drugs?" Laura Davisson, MD, once again asked the patient before her. While glucagon-like peptide 1 (GLP-1)...
Mounjaro vs. Ozempic: Is One Better Than the Other For Weight Loss?
MediaFeed via AOL· 6 days agoIn one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable...
Opinion: Finally, a cervical cancer screening that allows women more autonomy | CNN
CNN.com· 12 hours agoEditor’s Note: Dr. Megan L. Ranney is an emergency physician and dean of Yale School of Public...
NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy
KSAN - KLST San Angelo· 1 day agoWhat: In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from ...